Literature DB >> 19815659

Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods.

Björn Stollenwerk1, Stephanie Stock, Uwe Siebert, Karl W Lauterbach, Rolf Holle.   

Abstract

In decision modeling for health economic evaluation, bootstrapping and the Cholesky decomposition method are frequently used to assess parameter uncertainty and to support probabilistic sensitivity analysis. An alternative, Gauss's error propagation law, is rarely known but may be useful in some settings. Bootstrapping, the Cholesky decomposition method, and the error propagation law were compared regarding standard deviation estimates of a hypothetic parameter, which was derived from a regression model fitted to simulated data. Furthermore, to demonstrate its value, the error propagation law was applied to German administrative claims data. All 3 methods yielded almost identical estimates of the standard deviation of the target parameter. The error propagation law was much faster than the other 2 alternatives. Furthermore, it succeeded the claims data example, a case in which the established methods failed. In conclusion, the error propagation law is a useful extension of parameter uncertainty assessment.

Entities:  

Mesh:

Year:  2009        PMID: 19815659     DOI: 10.1177/0272989X09347015

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  9 in total

1.  Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach.

Authors:  Björn Stollenwerk; Thomas Welchowski; Matthias Vogl; Stephanie Stock
Journal:  Eur J Health Econ       Date:  2015-02-04

2.  Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.

Authors:  Björn Stollenwerk; Afschin Gandjour; Markus Lüngen; Uwe Siebert
Journal:  Eur J Health Econ       Date:  2012-12-30

3.  A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet.

Authors:  Björn Stollenwerk; Sergio Iannazzo; Ron Akehurst; Michael Adena; Andrew Briggs; Bastian Dehmel; Patrick Parfrey; Vasily Belozeroff
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

4.  A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting.

Authors:  Sonja Zindel; Stephanie Stock; Dirk Müller; Björn Stollenwerk
Journal:  BMC Health Serv Res       Date:  2012-07-09       Impact factor: 2.655

5.  Smoking and health-related quality of life in English general population: implications for economic evaluations.

Authors:  Matthias Vogl; Christina M Wenig; Reiner Leidl; Subhash Pokhrel
Journal:  BMC Public Health       Date:  2012-03-19       Impact factor: 3.295

6.  Multimorbidity and health-related quality of life in the older population: results from the German KORA-age study.

Authors:  Matthias Hunger; Barbara Thorand; Michaela Schunk; Angela Döring; Petra Menn; Annette Peters; Rolf Holle
Journal:  Health Qual Life Outcomes       Date:  2011-07-18       Impact factor: 3.186

7.  Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data.

Authors:  Emil Victor Gruber; Stephanie Stock; Björn Stollenwerk
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

8.  Cost of illness and economic burden of chronic lymphocytic leukemia.

Authors:  Carl Rudolf Blankart; Taika Koch; Roland Linder; Frank Verheyen; Jonas Schreyögg; Tom Stargardt
Journal:  Orphanet J Rare Dis       Date:  2013-02-20       Impact factor: 4.123

9.  Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers.

Authors:  Björn Stollenwerk; Stefan K Lhachimi; Andrew Briggs; Elisabeth Fenwick; Jaime J Caro; Uwe Siebert; Marion Danner; Andreas Gerber-Grote
Journal:  Health Econ       Date:  2014-03-04       Impact factor: 3.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.